Welcome to our dedicated page for Sono Tek SEC filings (Ticker: SOTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ultrasonic coating may sound simple, yet Sono-Tek’s SEC filings can stretch past 250 pages of dense engineering jargon and revenue breakouts. Finding where the company discloses semiconductor backlog or which executive just sold shares is time-consuming.
Stock Titan solves that pain. Our AI reads every Sono-Tek annual report 10-K simplified, every Sono-Tek quarterly earnings report 10-Q filing, and each Sono-Tek 8-K material events explained, then delivers plain-English summaries, key metrics, and red-flag alerts. Want immediate visibility into Sono-Tek insider trading Form 4 transactions? We stream Sono-Tek Form 4 insider transactions real-time so you can monitor executive stock moves before the market reacts.
Use our platform to:
- Compare R&D spending on new hydrogen-fuel coatings across successive 10-Qs.
- Track Sono-Tek proxy statement executive compensation to evaluate management incentives.
- Spot segment revenue shifts in medical device coatings without wading through footnotes.
- Receive AI-driven alerts when a fresh contract is disclosed in an 8-K.
From “understanding Sono-Tek SEC documents with AI” to detailed Sono-Tek earnings report filing analysis, Stock Titan keeps every filing type in one place—updated the moment EDGAR releases it and decoded so you can act with confidence.
Joseph Riemer, a director of Sono-Tek Corporation (SOTK), reported acquiring 7,018 shares on 08/21/2025 through the exercise of Sono-Tek stock options with an exercise price of $3.25 per share. The options are exercisable beginning 08/21/2026 and expire 08/21/2035. Following the reported transaction, Mr. Riemer beneficially owns 27,377 shares of common stock. The Form 4 was signed on 08/22/2025.
Carol O'Donnell, a director of Sono-Tek Corporation (SOTK), reported acquiring derivative securities on 08/21/2025. The filing shows acquisition of 7,018 Sono-Tek options with a $3.25 exercise price, exercisable beginning 08/21/2026 and expiring 08/21/2035. After the reported transaction, Ms. O'Donnell directly beneficially owned 25,377 shares of common stock. The Form 4 was signed 08/22/2025.
Sono-Tek director Kirk M. Warshaw reported exercising stock options on 08/21/2025, acquiring 7,018 shares of Sono-Tek Corp (SOTK) at an exercise price of $3.25 per share. Following the transaction the reporting person beneficially owns 7,018 shares directly. The Form 4 was signed on 08/22/2025.
Stephen James Bagley, CFO of Sono-Tek Corporation (SOTK), reported an insider acquisition of company options. The Form 4 shows an acquisition dated 08/21/2025 of 12,195 Sono-Tek options with an exercise price of $3.25 each. Those options become exercisable on 08/21/2026 and expire on 08/21/2035. Following the reported transaction, Mr. Bagley beneficially owns 38,700 shares of Sono-Tek common stock. The form is signed by the reporting person on 08/22/2025.
Christopher Coccio, a director of Sono-Tek Corp (SOTK), reported on Form 4 that on 08/21/2025 he acquired 29,240 stock options at an exercise price of $3.25. The options become exercisable on 08/21/2026 and expire on 08/21/2035, and they cover 29,240 shares of common stock. After the reported transaction, Mr. Coccio beneficially owned 99,744 shares. The filing is signed and dated 08/22/2025.
Maria Kuha, Vice President and director of Sono-Tek Corporation (SOTK), exercised options on 08/21/2025 to acquire 12,195 shares of common stock at an exercise price of $3.25 per share. The options become exercisable on 08/21/2026 and expire 08/21/2035. Following the transaction, Ms. Kuha directly beneficially owns 27,796 shares of Sono-Tek common stock.
Christopher Cichetti, a Vice President and director of Sono-Tek Corporation (SOTK), reported receipt of 21,951 stock options on 08/21/2025. The options have an exercise price of $3.25 per share, are exercisable beginning 08/21/2026 and expire on 08/21/2035. After this grant, Mr. Cichetti beneficially owns 79,763 shares of common stock on a direct basis. The Form 4 was signed and dated 08/22/2025.
Sono-Tek Corporation (SOTK) insider filing: CEO Stephen R. Harshbarger reported an option grant on 08/21/2025. The report shows acquisition of 29,268 Sono-Tek options with an exercise price of $3.25 per share.
The options become exercisable on 08/21/2026 and expire on 08/21/2035. Following the reported transaction, Mr. Harshbarger beneficially owns 83,184 shares (direct).
Stephen J. Bagley, CFO of Sono-Tek Corporation (SOTK), reported multiple open-market sales of common stock on August 18-19, 2025. The filings show four dispositions at prices between $3.34 and $3.36 per share, reducing his direct holdings stepwise to 34,254 shares. The Form 4 is signed and filed to disclose these changes in beneficial ownership.
FAQ
What is the current stock price of Sono Tek (SOTK)?
What is the market cap of Sono Tek (SOTK)?
